RECRUITING

Safest Choice of Antihypertensive Regimen for Postpartum Hypertension

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this investigator-initiated randomized control trial is to determine whether oral Nifedipine versus oral Labetalol is superior in controlling high blood pressures in the postpartum period.

Official Title

Safest Choice of Antihypertensive Regimen for Postpartum Hypertension: A Randomized Control Trial (SCARPH)

Quick Facts

Study Start:2024-12
Study Completion:2027-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05551104

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Female
  2. * Women who develop postpartum hypertension\* after delivery of the placenta or chronic hypertensive postpartum women who require medication for blood pressure control.
  3. * Postpartum hypertension requiring treatment are defined as systolic blood pressure greater than or equal to 140mmHg or diastolic blood pressure greater than or equal to 90mmHg on at least 2 occasions at least 4 hours apart, or systolic blood pressure greater than or equal to 160mmHg or diastolic blood pressure greater than 110mmHg sustained for more than 15 minutes.
  1. * History of moderate persistent asthma, coronary artery disease, heart failure, AV heart block, pulmonary edema
  2. * Contraindication to either Nifedipine or Labetalol
  3. * HR \<60 or \>110
  4. * Native language other than English or Spanish

Contacts and Locations

Study Contact

Ashra Denise B Tugung, BSc
CONTACT
9096515580
atugung@llu.edu
Nikia Gray-Hutto, RN, CCRP
CONTACT
9095584000
nhutto@llu.edu

Study Locations (Sites)

Loma Linda University Health
Loma Linda, California, 92350
United States

Collaborators and Investigators

Sponsor: Loma Linda University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12
Study Completion Date2027-12

Study Record Updates

Study Start Date2024-12
Study Completion Date2027-12

Terms related to this study

Keywords Provided by Researchers

  • Postpartum Hypertension

Additional Relevant MeSH Terms

  • Postpartum Complication
  • Maternal Hypertension
  • High Blood Pressure